Literature DB >> 18389859

[Postmortem dismemberment/mutilation--medicolegal and criminalistic evaluation of the autopsies performed by the Institute of Legal Medicine at the Hanover Medical School].

Yvonne Schulz1, Harald Mossakowski, Knut Albrecht, Dirk Breitmeier.   

Abstract

Among all the autopsies performed by the Institute of Legal Medicine at the Hanover Medical School between 1978 and 1998. 16 cases of postmortem dismemberment/mutilation were evaluable under criminalistic and medicolegal aspects. In the present study, particular attention was paid to the psychosocial circumstances of the perpetrator's and victim's lives and also to the classification of the different types of postmortem dismemberment/mutilation illustrated by case reports. Apart from an unfavourable personal life situation at the time of the offence, essential predisposing factors were: poor integration in society and family, occupational problems, drug abuse and mental diseases. As the interactions between these factors differ in every single case and may be combined with other factors, the analysis of such homicides should always be based on the assessment of the individual case.

Entities:  

Mesh:

Year:  2008        PMID: 18389859

Source DB:  PubMed          Journal:  Arch Kriminol        ISSN: 0003-9225


  3 in total

1.  Decapitation: a rare form of postmortem mutilation.

Authors:  Calle Winskog; Roger W Byard
Journal:  Forensic Sci Med Pathol       Date:  2015-09-08       Impact factor: 2.007

2.  Homicide and concealment of the corpse. Autopsy case series and review of the literature.

Authors:  Maria De Matteis; Arianna Giorgetti; Guido Viel; Chiara Giraudo; Claudio Terranova; Amalia Lupi; Paolo Fais; Alessandra Puggioni; Giovanni Cecchetto; Massimo Montisci
Journal:  Int J Legal Med       Date:  2020-05-30       Impact factor: 2.686

3.  Analysis of false start bone lesions produced by an electrical oscillating autopsy saw.

Authors:  Caroline Bernardi; Luísa Nogueira; Véronique Alunni; Gérald Quatrehomme
Journal:  Int J Legal Med       Date:  2019-02-13       Impact factor: 2.686

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.